VOYA Investment Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-256,120
Closed -$180K – 2540
2026
Q1
$180K Buy
256,120
+233,962
+1,056% +$218K ﹤0.01% 2129
2025
Q4
$34.3K Hold
22,158
– – ﹤0.01% 2372
2025
Q3
$35K Sell
22,158
-9,226
-29% -$16K ﹤0.01% 2411
2025
Q2
$68.4K Buy
31,384
+689
+2% +$1.67K ﹤0.01% 2554
2025
Q1
$83.8K Sell
30,695
-3,355
-10% -$13.2K ﹤0.01% 2468
2024
Q4
$142K Sell
34,050
-2,096
-6% -$7.92K ﹤0.01% 2494
2024
Q3
$141K Buy
36,146
+12
+0% +$51 ﹤0.01% 2579
2024
Q2
$142K Buy
36,134
+4,158
+13% +$17.9K ﹤0.01% 2581
2024
Q1
$134K Sell
31,976
-5,376
-14% -$25.2K ﹤0.01% 2564
2023
Q4
$176K Sell
37,352
-66,757
-64% -$260K ﹤0.01% 2615
2023
Q3
$325K Sell
104,109
-49,787
-32% -$200K ﹤0.01% 2268
2023
Q2
$706K Buy
153,896
+37,477
+32% +$172K ﹤0.01% 1880
2023
Q1
$576K Buy
116,419
+82,021
+238% +$404K ﹤0.01% 1970
2022
Q4
$188K Hold
34,398
– – ﹤0.01% 2603
2022
Q3
$224K Hold
34,398
– – ﹤0.01% 2536
2022
Q2
$163K Buy
+34,398
New +$169K ﹤0.01% 2472
2022
Q1
– Sell
-33,775
Closed -$344K – 2722
2021
Q4
$344K Buy
+33,775
New +$363K ﹤0.01% 2224

Other funds holding MXCT

VOYA Investment Management's MXCT Position: Q2 2026 in Review

VOYA Investment Management sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 256,120 shares — an estimated $180K sold.

VOYA Investment Management first reported a position in MXCT in Q4 2021 and held it in 17 quarters. The position peaked at $706K in Q2 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • VOYA Investment Management reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • VOYA Investment Management sold 256,120 MaxCyte shares in Q2 2026, an estimated $180K.
  • VOYA Investment Management first reported a position in MaxCyte in Q4 2021 and held it in 17 quarters.
  • VOYA Investment Management's MaxCyte position peaked at $706K in Q2 2023.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.